Gainers
- Valaris plc VAL shares rose 64.9% to $0.6502 in pre-market trading after gaining around 4% on Tuesday.
- Aerpio Pharmaceuticals, Inc. ARPO rose 51.5% to $2.00 in pre-market trading after the company announced a second clinical trial with funding from the MTEC to evaluate Razuprotafib for the prevention and treatment of ARDS in patients with moderate to severe coronavirus.
- Marathon Patent Group, Inc. MARA shares rose 29.3% to $4.28 in pre-market trading after dropping 14% on Tuesday. Marathon Patent, last week, reported the purchase of 700 M31S+ ASIC minders and shipment of 660 S-19 Pro Bitmain Miners.
- Whiting Petroleum Corporation WLL rose 26.9% to $1.37 in pre-market trading after surging more than 40% on Tuesday.
- Biofrontera AG BFRA rose 24.8% to $6.99 in pre-market trading.
- Acorda Therapeutics, Inc. ACOR rose 21.9% to $0.78 in pre-market trading after the company reported better-than-expected Q2 results.
- U.S. Energy Corp. USEG rose 21.8% to $6.53 in pre-market trading.
- MicroVision, Inc. MVIS rose 20.1% to $3.05 in pre-market trading ahead of quarterly earnings.
- Riot Blockchain, Inc. RIOT rose 18.2% to $4.02 in pre-market trading.
- Novavax, Inc. NVAX rose 17.1% to $184.00 in pre-market trading r after the company announced phase 1 data from its phase 1/2 trial was well-tolerated and had a reassuring safety profile. JP Morgan also upgraded the company's from Neutral to Overweight and raised its price target from $105 to $275.
- DouYu International Holdings Limited DOYU rose 16.6% to $17.26 in pre-market trading following reports that Tencent Holdings is in talks to merge Huya and DouYu International.
- Fulgent Genetics Inc FLGT rose 16.2% to $34.50 in pre-market trading after reporting an increase in Q2 EPS.
- Nxt-ID, Inc. NXTD rose 16.1% to $0.6806 in pre-market trading after declining 11% on Tuesday.
- LivePerson, Inc. LPSN rose 14.2% to $52.80 in pre-market trading after the company after the company reported better-than-expected Q2 sales and raised its FY20 guidance. KeyBanc and Needham also raised their price targets on the stock.
- HUYA Inc. HUYA rose 14% to $28.62 in pre-market trading following reports that Tencent Holdings is in talks to merge Huya and DouYu International.
- Key Tronic Corporation KTCC shares rose 14% to $8.21 in pre-market trading after the company reported Q4 results and issued FY21 guidance.
- Oasis Petroleum Inc. OAS rose 13.9% to $0.7760 in pre-market trading ahead of quarterly earnings.
- AgeX Therapeutics, Inc. AGE rose 13.8% to $1.73 in pre-market trading after surging 38% on Tuesday.
- Acorda Therapeutics Inc ACOR rose 13.8% to $0.73 in pre-market trading following better-than-expected Q2 EPS and sales results.
- Rigel Pharmaceuticals, Inc. RIGL rose 13.8% to $2.80 in pre-market trading following better-than-expected Q2 results.
- Aileron Therapeutics, Inc. ALRN rose 13.6% to $1.25 in pre-market trading. On Monday, Aileron Therapeutics reported the completion of enrollment in dose optimization expansion cohort of proof-of-concept Phase 1b study of ALRN-6924.
- Fiverr International Ltd. FVRR rose 13.2% to $118.00 in pre-market trading after reporting Q2 results.
- DIRTT Environmental Solutions Ltd. DRTT shares rose 12.6% to $1.88 in pre-market trading. DIRTT released Q2 results last week.
- GameStop Corp. GME rose 12.5% to $4.99 in pre-market trading after climbing about 7% on Tuesday.
- Square, Inc. SQ rose 10.8% to $151.55 in pre-market trading after the company reported better-than-expected Q2 results.
- Boot Barn Holdings Inc BOOT rose 10.7% to $22.50 in pre-market trading after the company reported upbeat Q1 results.
- DBV Technologies S.A. DBVT rose 10.3% to $2.58 in pre-market trading. HC Wainwright & Co. lowered the price target on the stock from $25 to $14. DBV Technologies shares tumbled around 43% on Tuesday after the company said the FDA has issued a Complete Response Letter regarding its BLA for investigational Viaskin Peanut, a non-invasive, once-daily epicutaneous patch to treat peanut allergies in children ages 4-11.
- Walt Disney Co DIS rose 6.7% to $125.10 in pre-market trading after the company reported Q2 earnings results. The company reported 57.5 million Disney+ paid subscribers as of June 27th.
- Clearwater Paper Corp CLW shares rose 6% to $40.55 in pre-market trading after the company reported upbeat Q2 results.
- Monster Beverage Corp MNST rose 4.5% to $81.50 in pre-market trading after the company reported better-than-expected Q2 results.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- Vapotherm, Inc. VAPO fell 28% to $38.00 in pre-market trading after the company reported Q2 results and issued Q3 outlook.
- New Relic, Inc. NEWR fell 19.1% to $59.50 in pre-market trading after the company issued weak Q2 EPS guidance. JP Morgan also downgraded the company's stock from Overweight to Neutral and lowered its price target from $72 to $61.
- Nikola Corporation NKLA fell 15.3% to $32.82 in pre-market trading after the company reported a Q2 loss of $0.16 per share. ValueAct dissolved its stake in Nikola as of July 31.
- Alterity Therapeutics Limited ATHE fell 14.6% to $2.93 in pre-market trading. Alterity Therapeutics shares climbed 154% on Tuesday after the company said topline results of an exploratory Phase 1b trial did not provide conclusive evidence of an analgesic benefit of KarXT on experimentally induced pain in healthy volunteers.
- Sintx Technologies, Inc. SINT fell 13% to $2.86 in pre-market trading. On Tuesday, O2TODAY reported an agreement to develop antimicrobial face masks with Sintx Technologies to help prevent spread of COVID-19 and other viral diseases.
- Cardlytics Inc CDLX fell 12.6% to $63.50 in pre-market trading after the company reported weaker-than-expected Q2 sales.
- Ossen Innovation Co., Ltd. OSN fell 9.7% to $3.82 in pre-market trading after climbing around 30% on Tuesday.
- Glu Mobile Inc. GLUU fell 9.5% to $8.85 in pre-market trading after the company reported worse-than-expected Q2 results.
- Invitae Corporation NVTA shares fell 9.4% to $30.00 in pre-market trading after the company reported a wider-than-expected Q2 loss. SVB Leerink lowered the price target for the stock from $40 to $34.
- EZCORP Inc EZPW fell 9.2% to $5.35 in pre-market trading after the company after the company reported a Q3 loss of $0.01 per share.
- Corcept Therapeutics Incorporated CORT fell 9.2% to $14.23 in pre-market trading following worse-than-expected Q2 sales..
- Upwork Inc. UPWK fell 8.6% to $16.00 in pre-market trading after the company reported Q2 results and issued Q3 sales guidance. Upwork appointed Jeff McCombs as CFO.
- WW International, Inc. WW fell 8% to $24.40 in pre-market trading after the company reported worse-than-expected Q2 results.
- DURECT Corporation DRRX fell 8% to $2.13 in pre-market trading. On Monday, Durect reported Q2 EPS of $0.07.
- NeoPhotonics CorpNPTN fell 8% to $9.15 in pre-market trading after the company reported Q2 earnings.
- Beyond Meat, Inc. BYND fell 7.8% to $131.26 in pre-market trading. Beyond Meat posted a Q2 loss of $0.02 per share.
- Callon Petroleum Company CPE fell 6.8% to $1.17 in pre-market trading after the company reported Q2 earnings results.
- Microchip Technology Inc. MCHP fell 6.8% to $100.00 in pre-market trading after reporting Q1 results.
- Zhongchao Inc. ZCMD fell 6.7% to $2.66 in pre-market trading. Zhongchao gained 21% on Tuesday after the company disclosed the renewal of its contract with J&J.
- Ethan Allen Interiors Inc. ETH fell 6.4% to $13.00 in pre-market trading after the company reported worse-than-expected Q4 sales.
- Sonnet BioTherapeutics Holdings, Inc. SONN fell 6.4% to $3.39 in pre-market trading. On Tuesday, Sonnet BioTherapeutics announced at-the-market warrant repricing and exchange, resulting in expected gross proceeds to the company of up to $10.5 million.
- EverQuote Inc EVER fell 6% to $50.88 in pre-market trading after the company reported worse-than-expected Q2 results.
- CHF Solutions, Inc. CHFS shares fell 5.7% to $0.91 in pre-market trading. CHF Solutions reported better-than-expected Q2 sales on Tuesday.
- Avalara Inc AVLR fell 5.5% to $130.00 in pre-market trading after the company announced a $500 million common stock offering.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksPre-Market OutlookMarketsMoversTrading IdeasHuman Resource & Employment ServicesIndustrialsInformation TechnologyInternet Software & ServicesPremarket MoversSemiconductorsTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in